The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Hepatitis C’s Impact – From Head to Toe

Back to News Homepage

Next

5 Hep C-Friendly Essential Oils for Valentine’s Day

AbbVie One Step Closer to Interferon-Free Therapy for Hepatitis C

February 4, 2014

Print this page

More than 2,300 patients from over 25 countries around the world have participated in the six Phase III trials being conducted by AbbVie to treat genotype 1 Hepatitis C virus infection using a regimen containing ABT-450.

AbbVie completes Phase III trial program for treatment of hepatitis C genotype 1

PBR Staff Writer Published 03 February 2014

AbbVie has completed its Phase III clinical trial program and released results of four additional studies designed to assess its investigational all-oral, interferon-free therapy with and without ribavirin (RBV) in patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection.

Continue reading this entire article:
http://clinicaltrials.pharmaceutical-business-review.com/news/abbvie-completes-phase-iii-trial-program-for-treatment-of-hepatitis-c-genotype-1-030214-4170646

No Comments - be the first!
Share
Share

Previous

Hepatitis C’s Impact – From Head to Toe

Back to News Homepage

Next

5 Hep C-Friendly Essential Oils for Valentine’s Day

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.